about
IFITM3 inhibits influenza A virus infection by preventing cytosolic entryThe dispanins: a novel gene family of ancient origin that contains 14 human membersEvolution of vertebrate interferon inducible transmembrane proteinsIFITM proteins restrict antibody-dependent enhancement of dengue virus infectionA novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factorDistinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virusISG56 and IFITM1 proteins inhibit hepatitis C virus replicationPhenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutationThe IFITM proteins inhibit HIV-1 infectionThe IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virusOsteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formationBone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfectaNew genes in bone development: what's new in osteogenesis imperfectaIfitm3 limits the severity of acute influenza in miceCharacterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient miceHyaluronan production by means of Has2 gene expression in chondrocytes is essential for long bone developmentEvolutionary dynamics of the interferon-induced transmembrane gene family in vertebratesContemporary Approaches for Identifying Rare Bone Disease Causing Genes.The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.Interferon-induced transmembrane protein 1 regulates endothelial lumen formation during angiogenesis.The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activityIdentification of an endocytic signal essential for the antiviral action of IFITM3.A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.HIV-1 mutates to evade IFITM1 restriction.Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells.Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutationThe IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type VKinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritisNonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.Identification of avian RIG-I responsive genes during influenza infectionCombined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.
P2860
Q21090493-E19240F3-5F2C-429E-9152-62114B6BEB4FQ21134765-6ECB86D7-AD41-42B9-85FE-8C0B7B03AF14Q21266712-87E8FF56-EBFE-4225-8CA6-408F8EDDC758Q24311739-3E56170F-72A5-4269-BCEE-C01ED80E16DDQ24336923-D8C8E8F7-0F6F-4BF8-B44B-AF40D0B6B9B2Q24337838-FB9B8431-5D26-4B24-8B7D-743E9C116FC3Q24339446-0895B0AC-D822-4F64-8891-8120B3525AA7Q24610376-001AA728-AF26-4241-B6E9-57FE0FF7F55EQ24629626-163DD799-8DAA-4896-8A7F-B6D678368F43Q24645420-1C5B9BDB-5A89-4E31-BF7C-464257914098Q26824200-271A1858-1D7E-481A-844E-8C9832BAF536Q26862184-77F7B69C-D97F-4434-BAB6-49C22C92B108Q26864752-86D97563-C509-4A28-A39E-3E619C3CB7AAQ27342563-76148070-2C95-47AC-81F9-1637021F255EQ28505226-03C59615-84B9-426B-A3AA-061B70A6BC4EQ28506987-92B82E70-2D5E-4700-9F8E-A2370ABF864FQ28712012-BE1935C5-F862-402C-81EC-DCA761D1614EQ30405866-25F885A0-75B2-4C1E-9546-3F1F1C868406Q30422163-EBED2D8B-DCD5-4B69-BD4A-676381584ADBQ30576600-C430E041-8A2E-484D-A58E-76D620BB5E02Q30973896-450DEB2D-CB2C-4471-A467-F3A8FE05FE8EQ33784795-B6E801FF-FD0D-4515-8172-843B66B40515Q34292231-A6C99191-4B9B-4247-94DB-DD1ECF599B25Q34627384-800BA1B2-40F9-4002-A992-CF746F29638BQ34761788-3148CC93-6935-4984-A867-B9AA4DA8B765Q34973809-471552DA-A2A8-4217-900B-9930B7219E85Q34995149-7C2DA6BD-478D-4C77-B21B-8212C1E28023Q35055113-23FEA6C8-F22D-47D0-BF44-B82BA26D1454Q35096701-C884BF36-B72A-4AD7-AC62-F884FC06512DQ35132933-1C7B3BDD-7120-4A41-80D1-F3DCF5D18F61Q35345123-0961A8F6-02BD-4523-8413-63D0E94089D1Q36039523-9A24D2E3-5837-423A-A218-66FF831F004FQ36090006-1F0C3F71-C22C-4ECB-9E58-5CA1557227EBQ36152886-CC2A7300-7AD7-40D4-844E-9CAFD81796ADQ36283505-8E8629DD-ABF2-474D-9394-C8BE33AA35C8Q36325726-063EE0D7-3AAF-48BD-A2BF-182D46B69F91Q36590447-DDBCB567-AE48-4C1F-89E9-BD69B12FF5EDQ36765053-D3911700-D1DF-45A5-B6C5-A65E7191EC10Q36832578-21BC44D5-34FA-4CFA-A4CA-D91288BEC738Q37239444-364716A2-264B-46AC-9A3C-CCD580D2F9D7
P2860
description
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im September 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/09/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/09/01)
@nl
наукова стаття, опублікована у вересні 2008
@uk
مقالة علمية (نشرت في سبتمبر 2008)
@ar
name
Bril: a novel bone-specific modulator of mineralization
@ast
Bril: a novel bone-specific modulator of mineralization
@en
Bril: a novel bone-specific modulator of mineralization
@nl
type
label
Bril: a novel bone-specific modulator of mineralization
@ast
Bril: a novel bone-specific modulator of mineralization
@en
Bril: a novel bone-specific modulator of mineralization
@nl
prefLabel
Bril: a novel bone-specific modulator of mineralization
@ast
Bril: a novel bone-specific modulator of mineralization
@en
Bril: a novel bone-specific modulator of mineralization
@nl
P2093
P2860
P3181
P356
P1476
Bril: a novel bone-specific modulator of mineralization
@en
P2093
Antonio Nanci
Eric Godin
Karine Sellin
Marie-Claude Bessette
Marie-Helene Gaumond
Patrick Salois
Paulo Tambasco de Oliveira
Pierre Moffatt
P2860
P304
P3181
P356
10.1359/JBMR.080412
P577
2008-09-01T00:00:00Z